Skip to content

admin

GPU-Accelerated Cloud Provider to Participate at 2022 ACEC Annual Convention

IronOrbit’s GPU-Accelerated Managed DaaS Provides a Foundation for Digital Transformation. Wednesday, May 18, 2022 – Anaheim Hills, CA – IronOrbit, a Gartner recognized turnkey Managed DaaS provider focused on significant GPU-intensive use cases, announces participation at the ACEC Annual Convention & Legislative Summit. This will be a welcomed return to the organization’s in-person national conference in Washington, D.C. from May 22-25. The annual convention brings… Read More »GPU-Accelerated Cloud Provider to Participate at 2022 ACEC Annual Convention

Developing Treatments for Multiple Cancers; Vaccine Candidates (Ebola, Sudan, and Marburg) Plus a Novel Heat Stable COVID-19 & Ricin Toxin Vaccines: Soligenix, Inc. (NASDAQ: SNGX)

Developing Treatments for Multiple Cancers; Vaccine Candidates (Ebola, Sudan, and Marburg) Plus a Novel Heat Stable COVID-19 & Ricin Toxin Vaccines: Soligenix, Inc. (NASDAQ: SNGX) – Focus on Commercializing Products for Cancers and Rare Diseases. – Successful Phase 3 Trial for Novel Photodynamic Therapy for Treatment of Cutaneous T-Cell Lymphoma (CTCL). – Vaccine Programs Incorporate Proprietary Heat Stabilization Platform Technology, known as ThermoVax(R). – Over… Read More »Developing Treatments for Multiple Cancers; Vaccine Candidates (Ebola, Sudan, and Marburg) Plus a Novel Heat Stable COVID-19 & Ricin Toxin Vaccines: Soligenix, Inc. (NASDAQ: SNGX)

Health and Wellness NASDAQ Brand, 3 Million Dollar Acquisition, 5 Million Dollar Share Buyback Plus Featured on CNN, ABC, CBS, Bloomberg, Washington Post, Vogue and Forbes: Jupiter Wellness, Inc. (NASDAQ: JUPW)

Health & Wellness NASDAQ Brand, 3 Million Dollar Acquisition, 5 Million Dollar Share Buyback Plus Featured on CNN, ABC, CBS, Bloomberg, Washington Post, Vogue & Forbes: Jupiter Wellness, Inc. (NASDAQ: JUPW) – Developer of CBD Based Treatments for Multiple Skin Care Applications. – New e-Commerce & Marketing Team with Experienced Industry Veterans. – JW-300 Treatment Demonstrated Efficacy for Developing Burns (sunburn) in Clinical Trial. –… Read More »Health and Wellness NASDAQ Brand, 3 Million Dollar Acquisition, 5 Million Dollar Share Buyback Plus Featured on CNN, ABC, CBS, Bloomberg, Washington Post, Vogue and Forbes: Jupiter Wellness, Inc. (NASDAQ: JUPW)

Continuous Robot Order Flow from Global Guardian Plus a Top Global Logistics Company for $AITX: Artificial Intelligence Technology Solutions (Stock Symbol: AITX)

Continuous Robot Order Flow from Global Guardian Plus a Top Global Logistics Company for $AITX: Artificial Intelligence Technology Solutions (Stock Symbol: AITX) AITX is the Future of AI & Robotics Innovation Specializing in Security for Corporations, Casinos & Colleges: – Artificial Intelligence and Robotic Solutions for Multiple Applications. – Expanding Sales Including Expectation of Large Orders from Global Small Box Retailer and Casino Operators. –… Read More »Continuous Robot Order Flow from Global Guardian Plus a Top Global Logistics Company for $AITX: Artificial Intelligence Technology Solutions (Stock Symbol: AITX)

Two New Listings In The Venetian Cove Club, Naples, FL

This intimate neighborhood of just 60 residences is situated on 600 feet of frontage on Outer Doctors Bay, a premier Park Shore location. Approx. 30 boat slips plus kayak storage are onsite for a nominal lease as available. 3500 Gulf Shore Blvd N #105, Naples, FL 34103 Two Bedrooms, Two Bathrooms, Turnkey $1,395,000 This first-floor residence exemplifies coastal luxury in one of the finest locations… Read More »Two New Listings In The Venetian Cove Club, Naples, FL

Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL)

Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL) – Developing Multiple Unique Cannabinoid & Psychedelic Medicine Therapies Targeted for U.S. FDA Approval and Registration. – Completed Loyalty Option Program to Raise A$23.6M Primarily Allocated to Clinical R&D Program. – Plans Underway to Acquire APIRx Pharmaceuticals USA, LLC. – Substantial Reduction in AHI in… Read More »Advancements for Anxiety, Sleep Apnea, Brain Injury, Lung Inflammation, Rheumatoid Arthritis & Inflammatory Bowel Disease: Incannex Healthcare Limited (NASDAQ: IXHL)

Undervalued NASDAQ Company to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference Jupiter Wellness, Inc. (NASDAQ: JUPW)

Undervalued NASDAQ Company to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference Jupiter Wellness, Inc. (NASDAQ: JUPW) Therapeutics & Wellness Products Company Featured on The Today Show, CNN, ABC, CBS, Animal Planet, AdWeek, Bloomberg, The Washington Post, Vogue, BuzzFeed, and Forbes – Developer of CBD Based Treatments for Multiple Skin Care Applications. – New e-Commerce & Marketing… Read More »Undervalued NASDAQ Company to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference Jupiter Wellness, Inc. (NASDAQ: JUPW)

The Global Cancer immunotherapy market is expected to reach 152 Billion by 2024 led by Astra Zeneca Nasdaq: AZN; Celgene Corp. (NASDAQ: CELG) Including Late Stage Newcomer; Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)

The Global Cancer immunotherapy market is expected to reach 152 Billion by 2024 led by Astra Zeneca Nasdaq: AZN; Celgene Corp. (NASDAQ: CELG) Including Late Stage Newcomer; Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Pharmaceutical Advancements for Oncology, Anti-Infectives in Adjunct Cancer Care, Unique Prescription Products and Stem Cell Therapies: Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) – Two Late-Stage Product Candidates Progressing to Phase 3 Clinical Trials. –… Read More »The Global Cancer immunotherapy market is expected to reach 152 Billion by 2024 led by Astra Zeneca Nasdaq: AZN; Celgene Corp. (NASDAQ: CELG) Including Late Stage Newcomer; Citius Pharmaceuticals, Inc. (NASDAQ: CTXR)